Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Opioids and cancer survival: are we looking in the wrong place? | BJA Open | 2022 | 37588274 | PubTator, text mining | PubMed |
| Development a novel multiepitope DNA vaccine against human SARS coronavirus-2: an immunoinformatic designing study. | Turk J Biol | 2022 | 37529092 | PubTator, text mining | PubMed |
| Lipid A heterogeneity and its role in the host interactions with pathogenic and commensal bacteria. | Microlife | 2022 | 37223360 | PubTator, text mining | PubMed |
| Mechanismbased role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis. | Front Immunol | 2022 | 36936475 | PubTator, text mining | PubMed |
| Effects of Methadone on the Toll-like Receptor 4 Expression in Human Non-Small Cell Lung Carcinoma A549 Cell Line Using In-silico and In vitro Techniques. | Adv Biomed Res | 2022 | 36798925 | PubTator, text mining | PubMed |
| The role of pyroptosis in endothelial dysfunction induced by diseases. | Front Immunol | 2022 | 36776394 | PubTator, text mining | PubMed |
| Bacteria derived extracellular vesicles in the pathogenesis and treatment of gastrointestinal tumours. | Front Oncol | 2022 | 36776356 | PubTator, text mining | PubMed |
| A pilot study on some critical immune elements in HBV infection: evidence of Alpha-1 Antitrypsin as an immunological biomarker. | Gastroenterol Hepatol Bed Bench | 2022 | 36762226 | PubTator, text mining | PubMed |
| Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis. | Front Pharmacol | 2022 | 36712680 | PubTator, text mining | PubMed |
| Understanding the development of Th2 cell-driven allergic airway disease in early life. | Front Allergy | 2022 | 36704753 | PubTator, text mining | PubMed |
| Rhodobacter capsulatus PG Lipopolysaccharide Blocks the Effects of a Lipoteichoic Acid, a Toll-Like Receptor 2 Agonist. | Acta Naturae | 2022 | 36694898 | PubTator, text mining | PubMed |
| Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like Receptors. | Viruses | 2022 | 36680092 | PubTator, text mining | PubMed |
| Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics. | Pharmaceuticals (Basel) | 2022 | 36678520 | PubTator, text mining | PubMed |
| Effects of Continuous LPS Induction on Oxidative Stress and Liver Injury in Weaned Piglets. | Vet Sci | 2022 | 36669023 | PubTator, text mining | PubMed |
| PvML1 suppresses bacterial infection by recognizing LPS and regulating AMP expression in shrimp. | Front Immunol | 2022 | 36643915 | PubTator, text mining | PubMed |
| Bioinformatics analysis of prognosis and immune microenvironment of immunological cell death-related gemcitabine-resistance genes in bladder cancer. | Transl Androl Urol | 2022 | 36632166 | PubTator, text mining | PubMed |
| Relationship between the Dietary Inflammatory Index Score and Cytokine Levels in Chinese Pregnant Women during the Second and Third Trimesters. | Nutrients | 2022 | 36615851 | PubTator, text mining | PubMed |
Inhibitory Mechanism of IL-6 Production by Orento in Oral Squamous Cell Carcinoma Cell Line CAL27 Stimulated by Pathogen-Associated Molecular Patterns from Periodontopathogenic Porphyromonas gingivalis. | Int J Mol Sci | 2022 | 36614140 | PubTator, text mining | PubMed |
| The Role of Pulmonary Surfactant Phospholipids in Fibrotic Lung Diseases. | Int J Mol Sci | 2022 | 36613771 | PubTator, text mining | PubMed |
| Multi-Omics Integration to Reveal the Mechanism of Sericin Inhibiting LPS-Induced Inflammation. | Int J Mol Sci | 2022 | 36613700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=33